Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.
GenScript Biotech Global Forum in London will explore the future of cell and gene therapy with Nobel Laureates and industry leaders on November 20, 2025.
Biotech firms face funding challenges after record highs
Biotech firms face funding challenges after pandemic-driven boom. Rising interest rates and cautious investors make fundraising difficult, potentially attracting big pharma acquisitions.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.